SCHEMBL2467169

SCHEMBL2467169

SCCSc1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.70
MAPK1 P28482 1/20 0.70
CYP1A2 P05177 3/20 0.47
CYP2D6 P10635 3/20 0.47
CYP2C19 P33261 3/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2C9 P11712 1/20 0.47
HIF1A Q16665 1/20 0.47
FFAR1 O14842 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
RAB9A P51151 4/20 0.44
NPC1 O15118 3/20 0.44
MTNR1A P48039 1/20 0.44
MTNR1B P49286 1/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
RECQL P46063 1/20 0.42
MAOA P21397 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL581983 0.86 ALDH1A1 (0.48) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL1493154 0.85 ALDH1A1 (0.64) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL10995099 0.83 ALDH1A1 (0.61) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL776647 0.83 ALDH1A1 (1.00) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL580864 0.82 ALDH1A1 (0.46) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
Methacrylic Acid SCHEMBL28756907 0.81 MTNR1A (0.51) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL22606565 0.79 ALDH1A1 (0.42) ALDH1A1MAPK1CYP3A4RAB9ANPC1
SCHEMBL17935510 0.78 ALDH1A1 (0.54) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL3880071 0.78
SCHEMBL420011 0.78 ALDH1A1 (0.78) ALDH1A1MAPK1CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106715502-B Polymerizable composition, transparent resin, optical material, plastic lens, and method for producing transparent resin 豪雅镜片泰国有限公司 2022-03-22 CN claimed
CN-107075065-B Polymerizable composition, transparent resin, optical material, plastic lens, and method for producing transparent resin 豪雅镜片泰国有限公司 2020-05-19 CN claimed
US-10611869-B2 Curable composition and cured product AGC Inc. (JP) 2020-04-07 US claimed
US-20190218325-A1 CURABLE COMPOSITION AND CURED PRODUCT AGC Inc. (JP) 2019-07-18 US claimed
JP-1226870-A None JP disclosed
US-12559852-B2 Composition for tin-silver alloy electroplating comprising a complexing agent BASF SE (DE) 2026-02-24 US disclosed
US-20250144003-A1 POLYHYDROXYALKANOATE COPOLYMER BEARING AN ACETOACETATE GROUP, COMPOSITION CONTAINING SAME AND COSMETIC USE THEREOF L'OREAL (FR) 2025-05-08 US disclosed
EP-4452197-A1 POLYHYDROXYALKANOATE COPOLYMER BEARING AN ACETOACETATE GROUP, COMPOSITION CONTAINING SAME AND COSMETIC USE THEREOF L'OREAL (FR) 2024-10-30 EP disclosed
CN-118201968-A Photocurable composition 三键有限公司 2024-06-14 CN disclosed
CN-118175988-A Photocurable composition for nail or artificial nail 三键有限公司 2024-06-11 CN disclosed
CN-118159584-A Curable resin composition and cured product thereof 株式会社大赛璐 2024-06-07 CN disclosed
CN-118103412-A Photocurable composition 三键有限公司 2024-05-28 CN disclosed
US-5594088-A PLASTICS WITH SULFIDE GROUPS, NONIONIC SURFACTANTS, SILICONE SURFACTANTS AND QUATERNARY AMMONIUM SALTS AS RELEASE AGENTS MITSUI TOATSU CHEMICALS, INC. (JP) 1997-01-14 US disclosed
US-5283341-A Catalytic alkylation NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1994-02-01 US disclosed
EP-0516982-A1 Process for producing a heterocyclic tertiary amine NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1992-12-09 EP disclosed
EP-0351073-A2 Lens comprising a resin having a large refractive index and process for preparing the lens MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-01-17 EP disclosed
JP-H01226870-A NOVEL THIOLCARBOXYLIC ACID ESTER NIPPON SHOKUBAI KAGAKU KOGYO CO LTD 1989-09-11 JP disclosed
EP-0164987-A2 7-Oxabicycloheptane substituted prostaglandin analogs E.R. Squibb & Sons, Inc. (US) 1985-12-18 EP disclosed
US-4555523-A 7-Oxabicycloheptane substituted thio prostaglandin analogs and their use in the treatment of thrombolytic disease E. R. SQUIBB & SONS, INC. (US) 1985-11-26 US disclosed
US-4355185-A BY HYDRAZINOLYSIS OF S-ALKYLISOTHIURONIUM SALTS AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) 1982-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559852-B2 Composition for tin-silver alloy electroplating comprising a complexing agent SLC13A3, GNA11, AP3D1 ALDH1A1 3242/4885MAPK1 1472/4885CYP1A2 1677/4885
US-20250144003-A1 POLYHYDROXYALKANOATE COPOLYMER BEARING AN ACETOACETATE GROUP, COMPOSITION CONTAINING SAME AND COSMETIC USE THEREOF KRT18, HCAR3, AKR1C3 ALDH1A1 1800/4885MAPK1 1559/4885CYP1A2 1364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.